Med-IQ

Advances in Targeted Therapy for Patient-Centered Management of Moderate-to-Severe Atopic Dermatitis

These activities address the importance of accurately assessing disease severity in patients with atopic dermatitis (AD) and incorporating validated patient-reported outcomes and patient feedback in the development of appropriate treatment plans. Additionally, these activities highlight recent clinical evidence regarding the use of agents that target AD pathophysiology and explore their integration into existing paradigms of clinical practice.

Related Resources

Note: The Related Resources material is not accredited for CME and, therefore, does not offer any CME/CE credit.

Faculty

Peck Ong, MD
Associate Professor of Clinical Pediatrics
Division of Clinical Immunology and Allergy
Children’s Hospital Los Angeles
Keck School of Medicine of USC
Los Angeles, CA

Peter A. Lio, MD
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Founding Director, Chicago Integrative Eczema Center 
Chicago, IL

Elaine C. Siegfried, MD
Professor of Pediatrics and Dermatology
Director, Division of Pediatric Dermatology
Department of Pediatrics
Saint Louis University School of Medicine
Cardinal Glennon Children’s Hospital
St. Louis, MO

Jonathan I. Silverberg, MD, PhD, MPH
Associate Professor
Director of Clinical Research
Director of Patch Testing
Department of Dermatology
George Washington University School of Medicine and Health Sciences
Washington, DC